CombiMatrix is a clinical diagnostic laboratory specializing in cytogenomic testing for prenatal diagnosis, miscarriage analysis, pediatric developmental disorders and preimplantation genetic screening (PGS). As a full-scale cytogenetic and cytogenomic laboratory, CombiMatrix offers chromosomal microarray analysis, standard and customized FISH, and high resolution karyotyping to help clinicians better care for their patients. At CombiMatrix, we pride ourselves on the clinical and molecular diagnostic expertise of our medical team, and the technical expertise of our scientists and laboratory technicians. Everyone at CombiMatrix is committed to providing you with the best care possible.
Irvine, US
65 (est)+17%
CombiMatrix is headquartered in Irvine, US

Key People at CombiMatrix

Judd Jessup

Judd Jessup

President & CEO
Scott Burell

Scott Burell

Scott Gottlieb

Scott Gottlieb

Robert E. Hoffman

Robert E. Hoffman

Richard D. Hockett

Richard D. Hockett

Chief Medical Officer
Karine Hovanes

Karine Hovanes

Laboratory Director

CombiMatrix Locations

Irvine, US
Irvine, US

CombiMatrix Metrics

CombiMatrix Summary

Market capitalization

$8.62 M

Closing share price

CombiMatrix's current market capitalization is $8.62 M.

CombiMatrix Financials

CombiMatrix's revenue is $10.1 M in FY, 2015 which is 25.44% increase from the previous period.
FY, 2013FY, 2014FY, 2015


$6.37 M$8.04 M$10.1 M

Gross profit

$2.84 M$3.61 M$4.64 M

Operating income

$-6.4 M$-8.75 M$-6.54 M

Operating expense total

$12.8 M$16.8 M$16.6 M

Net Income

$-3.94 M$-8.71 M$-6.6 M

Operating cash flow

$9.92 M$-11.3 M$-357 K

    CombiMatrix Market Value History

    We estimate that CombiMatrix's current employees are approximately 11% female and 89% male.

    CombiMatrix Online Presence

    CombiMatrix Company Life

    You may also be interested in